Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18720972 | 0.75 | CYP2C9 (0.30) | — | |
| SCHEMBL8162200 | 0.74 | ALDH1A1 (0.36) | ALDH1A1GAAUSP2MAPTTDP1 | |
| SCHEMBL29281402 | 0.72 | EPHX1 (0.33) | ALDH1A1GAAKDM4ECYP1A2 | |
| SCHEMBL29281396 | 0.72 | CYP1A2 (0.32) | ALDH1A1GAAKDM4ECYP1A2CYP2D6 | |
| SCHEMBL12384745 | 0.72 | ALDH1A1 (0.39) | ALDH1A1GAAUSP2MAPTTDP1 | |
| SCHEMBL10013221 | 0.72 | ALDH1A1 (0.39) | ALDH1A1GAAUSP2MAPTTDP1 | |
| SCHEMBL15465744 | 0.72 | TSHR (0.32) | — | |
| SCHEMBL9805888 | 0.71 | KDM4E (0.30) | ALDH1A1GAATDP1KDM4EPOLB | |
| SCHEMBL17684091 | 0.70 | — | — | |
| SCHEMBL14600298 | 0.70 | ALDH1A1 (0.33) | ALDH1A1GAAUSP2MAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250171390-A1 | PROCESS FOR PREPARING UNSATURATED ALDEHYDES | FIRMENICH SA (CH) | 2025-05-29 | — | — | US | disclosed |
| EP-4486732-A1 | PROCESS FOR PREPARING UNSATURATED ALDEHYDES | Firmenich SA (CH) | 2025-01-08 | — | — | EP | disclosed |
| CN-118829633-A | Process for preparing unsaturated aldehydes | 弗门尼舍有限公司 | 2024-10-22 | — | — | CN | disclosed |
| WO-2023166005-A1 | PROCESS FOR PREPARING UNSATURATED ALDEHYDES | FIRMENICH SA (CH) | 2023-09-07 | — | — | WO | disclosed |
| CN-116018334-A | Process for preparing 3- (cyclohex-1-en-1-yl) propanal derivatives | 弗门尼舍有限公司 | 2023-04-25 | — | — | CN | disclosed |
| EP-4153552-A2 | PROCESS AND INTERMEDIATES FOR PREPARING 3-(CYCLOHEX-1-EN-1-YL) PROPANAL DERIVATIVES | Firmenich SA (CH) | 2023-03-29 | — | — | EP | disclosed |
| WO-2022049036-A2 | PROCESS FOR PREPARING 3-(CYCLOHEX-1-EN-1-YL)PROPANAL DERIVATIVES | FIRMENICH SA (CH) | 2022-03-10 | — | — | WO | disclosed |
| US-5929298-A | Process for preparing conjugated dienes using substituted rhenium trioxide | EASTMAN CHEMICAL COMPANY (US) | 1999-07-27 | — | — | US | disclosed |
| US-5929298-A | Process for preparing conjugated dienes using substituted rhenium trioxide | EASTMAN CHEMICAL COMPANY (US) | 1999-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171390-A1 | PROCESS FOR PREPARING UNSATURATED ALDEHYDES | ALDH1A1, AOX1, ALDH2 | ALDH1A1 1/4885GAA 630/4885USP2 1170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.